Abstract
The aim of this study was to investigate the effects of microtubule organization inhibitor Paclitaxel and natural standardized flavonoid extract from the bark of French maritime pine (pycnogenol) on mitochondrial dynamics in breast cancer cell lines which have non-metastatic (67NR) and high metastatic (4T1) potential. 67NR and 4T1 breast cancer lines were cultured in DMEM-F12 medium and passaged every 2–3 days. Experimental groups is control group, paclitaxel group and pycnogenol group. We used 0.5 µM for Paclitaxel and 20 µg for pycnogenol and cells incubated 24 h. Mfn-1 antibody for mitochondrial fusion, Drp-1 antibody for mitochondrial fission, Pink1 antibody for mitophagy were evaluated using indirect immunohistochemistry technique. The distributions of immunohistochemical intensities of primary antibodies were graded semi-quantitatively. Scores of staining intensities were graded as mild, moderate, strong and very strong statistics were comparatively evaluated by using H-score. It was found that the usage of paclitaxel and pycnogenol were helpful in terms of cancer therapy. Immunohistochemical studies showed that Mfn-1, Drp-1 and Pink1 expressions significantly changed experimental groups for mitochondrial dynamics. Therefore, our study revealed that mitochondrial dynamics may be a potential target to improve the antineoplastic activity of paclitaxel and pycnogenol in breast cancer in the future.
Conflicts of Interest
The authors declare no conflict of interest.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).